SMi reports: West Pharmaceutical Services to Host a Free Exclusive Webinar on Prefilled Syringe Elastomer Components High-Quality Solutions for Sensitive Molecules, taking place on 16 th July 2020.

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced positive three-year (156-week) results for EYLEA HD (aflibercept) Injection 8 mg in patients with wet age-related macular degeneration ...

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of EYLEA HD (aflibercept) Injection 8 mg for treating ...

Regeneron Pharmaceuticals announced positive three-year results from an extension study of EYLEA HD (aflibercept) Injection 8 mg for treating wet age-related macular degeneration (wAMD).

The pre-filled syringes industry is growing at an exponential rate. With increasing demand for self-administration, a rise in biologics, large-volume delivery and the delayed EU MDR at the ...

The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...

With the safePICO self-fill blood gas syringe, you can improve your mixing and get results you can trust. Mixing ball helps you obtain a homogeneous sample SafeTIPCAP minimizes the risk of blood ...

A step-by-step guide to help you fill out a W-4 Nora Carol Photography / Getty Images You're about to begin that much-needed, new job and your employer hands you an IRS Form W-4 to fill out and ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR trial investigating EYLEA HD (aflibercept) Injection 8 mg. The QUASAR trial ...

QUASAR trial showed EYLEA HD achieved non-inferior visual acuity gains with extended 8-week dosing intervals in macular edema secondary to retinal vein occlusion. PULSAR trial extension demonstrated ...